When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Melatonin as a medication and supplement - Wikipedia

   en.wikipedia.org/wiki/Melatonin_as_a_medication...

   Melatonin is a safer alternative than clonazepam in the treatment of REM sleep behavior disorder – a condition associated with the synucleinopathies like Parkinson's disease and dementia with Lewy bodies. [32] [33] [34] However, clonazepam may be more effective. [35]

3. Memantine - Wikipedia

   en.wikipedia.org/wiki/Memantine

   Memantine, sold under the brand name Namenda among others, is a medication used to slow the progression of moderate-to-severe Alzheimer's disease. [10] [11] [8] It is taken by mouth. [10] [8] Common side effects include headache, constipation, sleepiness, and dizziness. [10] [11] Severe side effects may include blood clots, psychosis, and heart ...

4. Changing Your Diet and Lifestyle May Slow Down Alzheimer's - AOL

   www.aol.com/changing-diet-lifestyle-may-slow...

   L ately, the biggest news in Alzheimer’s has been around a new drug treatment that can slow cognitive decline by nearly 30% among people in the early stages of the disease. In coming months, the ...

5. Nootropic - Wikipedia

   en.wikipedia.org/wiki/Nootropic

   Panax ginseng – A Cochrane review found possible "improvement of some aspects of cognitive function, behavior and quality of life", but concluded that "there is a lack of convincing evidence to show a cognitive enhancing effect of Panax ginseng in healthy participants and no high quality evidence about its efficacy in patients with dementia."

6. The Surprising Medication That May Lower Your Risk of Alzheimer's

   www.aol.com/lifestyle/surprising-medication-may...

   For premium support please call: 800-290-4726 more ways to reach us

7. U.S. approves Alzheimer's drug that modestly slows disease - AOL

   www.aol.com/news/alzheimers-drug-modestly-slows...

   This Dec. 21, 2022 image provided by Eisai in January 2023, shows vials and packaging for their medication Leqembi. On Friday, Jan. 6, 2023, U.S. health officials approved Leqembi, a new Alzheimer ...